FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 第 1 頁 共 10 頁 v 1.1.1 FF301 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 雅天妮集團有限公司（於百慕達註冊成立之有限公司) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00789 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 6,000,000,000 | HKD | | 0.05 HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 6,000,000,000 | HKD | | ...

截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00789 | 說明 | | 普通股 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 1,323,968,128 | | 0 | | 1,323,968,128 | | 增加 / 減少 (-) | | | | | | | | | | 本月底結存 | | | | 1,323,968,128 | | 0 | | 1,323,968,128 | 第 2 頁 共 10 頁 v 1.1.1 公司名稱: 雅天妮集團有限公司（於百慕達註冊成立之有限公司) 呈交日期: 2025年10月3日 I. 法 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 雅天妮集團有限公司 （於百慕達註冊成立之有限公司） （股份代號：789） 於二零二五年九月二十九日舉行的 股東週年大會的投票結果 Artini Holdings Limited 謹 此 提 述 雅 天 妮 集 團 有 限 公 司（「本公司」）日 期 均 為 二 零 二 五 年 七 月 三 十 日 之 通 函（「該通函」）及 召 開 股 東 週 年 大 會 之 通 告（「股東週年大會通告」），內 容 有 關 本 公 司 於 二 零 二 五 年 九 月 二 十 九 日（星 期 一）舉 行 之 股 東 週 年 大 會（「股東週年大 會」）。除 文 義 另 有 所 指 外，本 公 告 所 用 詞 彙 與 該 通 函 所 界 定 者 具 有 相 同 涵 義。 董 事 會 宣 佈，於 股 東 週 年 大 會 通 告 所 載 及 於 股 東 週 年 大 會 上 ...

Core Viewpoint - Lin Chenjie increased his stake in Yatani Group (00789) by purchasing 200,000 shares at an average price of HKD 0.415 per share, totaling HKD 83,000, raising his ownership to approximately 713 million shares, which represents 53.84% of the company [1] Group 1 - Lin Chenjie acquired 200,000 shares of Yatani Group on September 24 [1] - The average purchase price was HKD 0.415 per share, amounting to a total investment of HKD 83,000 [1] - Following this transaction, Lin Chenjie's total shareholding in Yatani Group increased to approximately 713 million shares, equating to a 53.84% ownership stake [1] Group 2 - The transaction involved other related parties, including Fuxing Investment Development (Shenzhen) Co., Ltd. and Chen Long [1]

Core Insights - Lin Chenjie increased his stake in Yatani Group (00789) by purchasing 200,000 shares at an average price of HKD 0.415 per share, totaling HKD 83,000 [1] - Following this transaction, Lin's total shareholding in Yatani Group is approximately 713 million shares, representing a 53.84% ownership stake [1] - The transaction also involves other related parties, including Fuxing Investment Development (Shenzhen) Co., Ltd. and Chen Long [1]

Core Viewpoint - Yatani Group (00789) experienced a significant stock price increase, rising over 48% during trading, with a current increase of 38.33% to HKD 0.142, and a trading volume of HKD 2.2969 million [1] Group 1: Strategic Partnership - Yatani Group announced a strategic cooperation agreement with Baiyunshan Weiyi, aimed at jointly developing products in the health and wellness sector and expanding market reach [1] - The collaboration will focus on innovative products in areas such as natural plant extracts, functional health products, and personal care items [1] - Both companies plan to promote the developed products and existing related products in overseas markets [1] Group 2: Business Development Strategy - The announcement aligns with Yatani Group's recent efforts to expand its sales business in beauty and health products [1] - The board believes that this strategic partnership will leverage Yatani Group's international market and sales platform advantages alongside Baiyunshan Weiyi's technical, brand, and product strengths, creating synergies [1] - This initiative is expected to enrich the company's product portfolio and enhance its core competitiveness in the health and wellness sector, opening new revenue streams [1]

Core Viewpoint - Yatani Group (00789) has seen a significant stock price increase of over 48% during trading, attributed to the announcement of a strategic cooperation agreement with Baiyunshan Weiyi to jointly develop products in the health sector [1] Group 1: Strategic Cooperation - The agreement aims to collaborate on the research and development of products in the health sector, including natural plant extracts, functional health products, and personal care items [1] - Both companies plan to market the developed products and existing related products in overseas markets [1] Group 2: Business Development Strategy - Yatani Group has been actively expanding its sales of beauty and health products in recent years, aligning with the strategic cooperation with Baiyunshan Weiyi [1] - The board believes that this partnership will leverage Yatani's international market and sales platform alongside Baiyunshan Weiyi's technology, brand, and product advantages, creating synergies [1] - This collaboration is expected to enrich Yatani's product portfolio and enhance its core competitiveness in the health sector, potentially opening new revenue streams [1]

Group 1 - The core point of the news is that Atnini Group has signed a strategic cooperation agreement with Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach, with a cooperation period of one year [1] - The strategic cooperation will focus on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - Baiyunshan Weiyi will provide brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion related to health products [1] Group 2 - The cooperation aligns with Atnini Group's business development strategy and long-term layout in the health industry, aiming to leverage the advantages of both companies [2] - The board believes that this strategic cooperation will enhance the product portfolio and core competitiveness in the health sector, potentially opening new revenue sources [2] - The agreement is considered beneficial for the company and its shareholders overall [2]

Group 1 - The core point of the article is that Atnini Group has signed a strategic cooperation agreement with Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach, with a cooperation period of one year [1][2] - The strategic cooperation will focus on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - Baiyunshan Weiyi will provide brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion related to health products [1] Group 2 - The cooperation aligns with Atnini Group's business development strategy and long-term layout in the health industry, aiming to leverage the strengths of both companies for synergistic effects [2] - This partnership is expected to enrich Atnini Group's product portfolio and enhance its core competitiveness in the health sector, potentially opening new revenue streams [2] - The board of directors believes that the agreement with Baiyunshan Weiyi is in the overall interest of the company and its shareholders [2]

Group 1 - The core point of the article is the strategic cooperation agreement signed between Yatani Group and Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach [1][2] Group 2 - The strategic cooperation agreement is set for a duration of one year and focuses on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - The collaboration aims to leverage Baiyunshan Weiyi's brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion [1] - This partnership aligns with the company's strategy to expand its beauty and health product sales, enhancing its core competitiveness in the health sector and opening new revenue streams [2]